Xie L, Fang J, Yu J, Zhang W, He Z, Ye L
MedComm (2020). 2023; 4(5):e390.
PMID: 37829505
PMC: 10565399.
DOI: 10.1002/mco2.390.
Olvera A, Noguera-Julian M, Kilpelainen A, Romero-Martin L, G Prado J, Brander C
Vaccines (Basel). 2020; 8(3).
PMID: 32781672
PMC: 7565482.
DOI: 10.3390/vaccines8030444.
Gibson K, Steiner M, Rentia U, Bendall M, Perez-Losada M, Crandall K
Viruses. 2020; 12(7).
PMID: 32674515
PMC: 7412389.
DOI: 10.3390/v12070758.
Carlson J, Du V, Pfeifer N, Bansal A, Tan V, Power K
Nat Med. 2016; 22(6):606-13.
PMID: 27183217
PMC: 4899163.
DOI: 10.1038/nm.4100.
Mothe B, Hu X, Llano A, Rosati M, Olvera A, Kulkarni V
J Transl Med. 2015; 13:60.
PMID: 25879820
PMC: 4336696.
DOI: 10.1186/s12967-015-0392-5.
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.
Ruiz-Riol M, Llano A, Ibarrondo J, Zamarreno J, Yusim K, Bach V
J Infect Dis. 2014; 211(6):936-46.
PMID: 25249264
PMC: 4416125.
DOI: 10.1093/infdis/jiu534.
Distinctive features of CD4+ T cell dysfunction in chronic viral infections.
Morou A, Palmer B, Kaufmann D
Curr Opin HIV AIDS. 2014; 9(5):446-51.
PMID: 25023623
PMC: 4231289.
DOI: 10.1097/COH.0000000000000094.
Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.
Penezina O, Krueger N, Rodriguez-Chavez I, Busch M, Hural J, Kim J
Clin Vaccine Immunol. 2014; 21(3):391-8.
PMID: 24403525
PMC: 3957658.
DOI: 10.1128/CVI.00748-13.
Functional conservation of HIV-1 Gag: implications for rational drug design.
Li G, Verheyen J, Rhee S, Voet A, Vandamme A, Theys K
Retrovirology. 2013; 10:126.
PMID: 24176092
PMC: 4228425.
DOI: 10.1186/1742-4690-10-126.
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.
Mothe B, Llano A, Ibarrondo J, Zamarreno J, Schiaulini M, Miranda C
PLoS One. 2012; 7(1):e29717.
PMID: 22238642
PMC: 3251596.
DOI: 10.1371/journal.pone.0029717.
Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.
Blish C, Dogan O, Jaoko W, McClelland R, Mandaliya K, Odem-Davis K
AIDS. 2012; 26(5):643-6.
PMID: 22210637
PMC: 3511787.
DOI: 10.1097/QAD.0b013e3283509a0b.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreno J
J Transl Med. 2011; 9:208.
PMID: 22152067
PMC: 3292987.
DOI: 10.1186/1479-5876-9-208.
Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.
Zembe L, Burgers W, Jaspan H, Bekker L, Bredell H, Stevens G
PLoS One. 2011; 6(10):e26096.
PMID: 22022524
PMC: 3192159.
DOI: 10.1371/journal.pone.0026096.
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.
Almeida C, Roberts S, Laird R, McKinnon E, Ahmad I, Keane N
Vaccine. 2010; 28(37):6052-7.
PMID: 20619380
PMC: 2949439.
DOI: 10.1016/j.vaccine.2010.06.091.
Epitope mapping of HIV-specific CD8+ T cells in a cohort dominated by clade A1 infection.
McKinnon L, Mao X, Kimani J, Wachihi C, Semeniuk C, Mendoza M
PLoS One. 2009; 4(9):e6965.
PMID: 19750221
PMC: 2735720.
DOI: 10.1371/journal.pone.0006965.
Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.
Malhotra U, Nolin J, Horton H, Li F, Corey L, Mullins J
Vaccine. 2009; 27(48):6678-87.
PMID: 19747576
PMC: 2845637.
DOI: 10.1016/j.vaccine.2009.08.093.
HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering.
Matthews P, Leslie A, Katzourakis A, Crawford H, Payne R, Prendergast A
J Virol. 2009; 83(9):4605-15.
PMID: 19244334
PMC: 2668443.
DOI: 10.1128/JVI.02017-08.
Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.
Serwanga J, Shafer L, Pimego E, Auma B, Watera C, Rowland S
PLoS One. 2009; 4(1):e4188.
PMID: 19142234
PMC: 2617765.
DOI: 10.1371/journal.pone.0004188.
Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.
Wang Y, Li B, Carlson J, Streeck H, Gladden A, Goodman R
J Virol. 2008; 83(4):1845-55.
PMID: 19036810
PMC: 2643763.
DOI: 10.1128/JVI.01061-08.
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.
Yerly D, Heckerman D, Allen T, Suscovich T, Jojic N, Kadie C
J Immunol. 2008; 181(9):6361-70.
PMID: 18941227
PMC: 5918411.
DOI: 10.4049/jimmunol.181.9.6361.